CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
56.56
-0.77 (-1.34%)
At close: Sep 18, 2026, 4:00 PM EDT
57.20
+0.64 (1.13%)
After-hours: Sep 18, 2026, 7:59 PM EDT
CRISPR Therapeutics AG Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $88 | Buy | Maintains | $88 | +55.59% | Sep 4, 2026 |
| Needham | Needham | Buy Maintains $82 | Buy | Maintains | $82 | +44.98% | Sep 1, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $76 | Buy | Maintains | $76 | +34.37% | Aug 31, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $80 | Buy | Reiterates | $80 | +41.44% | Aug 31, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 29, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $60 | Hold | Maintains | $60 | +6.08% | Aug 28, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Reiterates $48 → $55 | Hold | Reiterates | $48 → $55 | -2.76% | Aug 10, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $83 → $82 | Buy | Reiterates | $83 → $82 | +44.98% | Aug 5, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.